Portfolio News

Corbus Pharmaceuticals Announces Acceptance of Three Abstracts for Presentation at EULAR 2018 Annual Meeting

Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases, announced today that its abstracts have been accepted for presentation at the European League Against Rheumatism ("EULAR") 2018 Annual Meeting being held June 13-16, 2018 in Amsterdam, Netherlands. Read more >>
Read more...

Wasabi Introduces Wasabi Ball Data Transfer Appliance

Wasabi, the hot cloud storage company, today introduced the Wasabi Ball transfer appliance, a simple, portable plug-and-play data transport solution that allows users to transfer large-scale datasets to and from Wasabi Hot Cloud Storage. Wasabi Ball addresses common challenges associated with large-scale data transfers by eliminating the high network costs and long transfer times often associated with moving large data amounts over the internet. Read more >>
Read more...

Myomo® Application for Medicare Codes Receives Favorable Preliminary Decision

Myomo, Inc., a wearable medical robotics company, announces that the Centers for Medicare & Medicaid Services ("CMS") has published a favorable preliminary decision regarding the Company’s application for Healthcare Common Procedure Coding System (HCPCS) “L” codes. Myomo had filed its application in December 2017 to have CMS establish two new Level II HCPCS codes to describe “microprocessor-controlled, custom fabricated upper extremity braces. Read more >>
Read more...

Shiva Kashalkar: Integrating Passion and Business to Create “Netflix” for Toys

When Shiva Kashalkar’s daughter was eight months old, she realized that she was paying several hundred dollars every month for toys that she would only play with for a few days. The clutter from unused toys drove her crazy. Talking with other parents, she learned this was a common issue and became inspired to start Green Piñata Toys. Read more >>
Read more...

Platelet BioGenesis Licenses Induced Pluripotent Stem Cell Technology from iPS Academia Japan

Platelet BioGenesis, a pioneer in the production of functional human platelets (PLTs+™) from stem cells, announced it has licensed patents related to induced pluripotent stem cells (“iPS cells”) from iPS Academia Japan’s patent portfolio. This non-exclusive agreement moves Platelet BioGenesis closer to its goal of producing functional human platelets at commercial scale. Read more >>
Read more...

Platelet BioGenesis Licenses Induced Pluripotent Stem Cell Technology from iPS Academia Japan

Platelet BioGenesis, a pioneer in the production of functional human platelets (PLTs+™) from stem cells, announced it has licensed patents related to induced pluripotent stem cells (“iPS cells”) from iPS Academia Japan’s patent portfolio. This non-exclusive agreement moves Platelet BioGenesis closer to its goal of producing functional human platelets at commercial scale. Read more >>
Read more...